◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Tsumura & Co. (4540) Financial History

Name: Tsumura & Co. (4540) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Tsumura & Co. (4540) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tokyo, Japan with about 4,923 employees. Its market capitalization is roughly JPY 280 billion. In the fiscal year ended 2026-03-31, 4540 reported JPY 192.6B in revenue and JPY 28.1B in net income.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Interactive charts & full statements →

4540 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 192.6B	JPY 181.1B	JPY 150.8B	JPY 140.0B	—
Gross Profit	JPY 91.5B	JPY 90.6B	JPY 68.8B	JPY 68.3B	—
Operating Income (EBIT)	JPY 35.2B	JPY 40.1B	JPY 20.0B	JPY 20.9B	—
Net Income	JPY 28.1B	JPY 32.4B	JPY 16.7B	JPY 16.5B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4540 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 10.3B)	(JPY 9.0B)	(JPY 5.1B)	(JPY 4.9B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4540 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 592.8B	JPY 464.4B	JPY 428.3B	JPY 396.8B
Total Liabilities	JPY 221.2B	JPY 134.3B	JPY 132.9B	JPY 124.6B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4540 viewer.

4540 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4523 · Eisai Co., Ltd. — $1.40 trillion
4151 · Kyowa Kirin Co., Ltd. — $1.34 trillion
4506 · Sumitomo Pharma Co., Ltd. — $603 billion
1276 · Jiangsu Hengrui Pharmaceuticals Co.,Ltd — $382 billion
4516 · Nippon Shinyaku Co., Ltd. — $242 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion
4887 · Sawai Group Holdings Co., Ltd. — $184 billion
4553 · Towa Pharmaceutical Co., Ltd. — $182 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4539 All “0-9” companies 4543 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.